Marine Natural Products in Preclinical Cancer Studies: Ten Years of Advanced Total Synthesis
Marine Drugs · 07.11.2025 · 23 (11) · 430
DOI: 10.3390/md23110430 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Marine Drugs, online erschienen am 07.11.2025. Verfasst von Ester Colarusso und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, SA, Italy. Hauptthemen laut MEDLINE: Antineoplastic Agents, Aquatic Organisms, Biological Products. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca, Ministero dell’Università e della Ricerca.
Abstract (Originalsprache)
Marine ecosystems represent an exceptional reservoir of structurally diverse metabolites with remarkable pharmacological potential. Over the past decades, the exploration of marine organisms has led to the discovery of an ever-expanding number of bioactive compounds. Many of these metabolites display highly original chemical scaffolds that are not typically found in terrestrial organisms, offering new opportunities for drug discovery. Among the most promising applications is their development as anticancer agents, given their ability to interfere with key cellular processes. This review highlights marine natural products currently under investigation in preclinical studies as potential anticancer lead compounds. The molecules are classified into major structural families: aromatic and heterocyclic alkaloids, terpenes and their derivatives, macrolide frameworks, and diverse peptide-based scaffolds, alongside other complex classes (polyketides, thiazole lipids, alkylamino alcohols, and pyrrolocarbazole derivatives). A particular emphasis has been placed on the role of total synthesis over the last decade. Advances in synthetic methodology have not only enabled the production of these complex metabolites in sufficient quantities but have also facilitated the development of novel chemotherapeutic agents. To overcome the challenges of limited natural availability, the advanced synthetic approaches are crucial for harnessing the full therapeutic potential of marine-derived compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, SA, Italy.
- Institute of Biomolecular Chemistry (ICB), Consiglio Nazionale Delle Ricerche (CNR), Via Campi Flegrei 34, 80078 Pozzuoli, NA, Italy.
- Department of Biosciences and Territory, University of Molise, Contrada Fonte Lappone, 86090 Pesche, IS, Italy.
ORCID-Profile: Ester Colarusso, Assunta Giordano, Gianluigi Lauro
Förderung
- Ministero dell'Università e della Ricerca
- Ministero dell’Università e della Ricerca
Zitieren
APA
Colarusso, E., Giordano, A., Chini, M. G., Bifulco, G., & Lauro, G. (2025). Marine Natural Products in Preclinical Cancer Studies: Ten Years of Advanced Total Synthesis. Marine Drugs, 23(11), 430. https://doi.org/10.3390/md23110430
Vancouver
Colarusso E, Giordano A, Chini MG, Bifulco G, Lauro G. Marine Natural Products in Preclinical Cancer Studies: Ten Years of Advanced Total Synthesis. Marine Drugs. 2025;23(11):430. doi:10.3390/md23110430
BibTeX
@article{Colarusso2025,
author = {Colarusso, Ester and Giordano, Assunta and Chini, Maria Giovanna and Bifulco, Giuseppe and Lauro, Gianluigi},
title = {Marine Natural Products in Preclinical Cancer Studies: Ten Years of Advanced Total Synthesis},
journal = {Marine Drugs},
year = {2025},
volume = {23},
number = {11},
pages = {430},
doi = {10.3390/md23110430}
}
EUVIMED